


2 Biosimilars Make Their Way Toward the European Market
EMA Panel Recommends Nod for Sanofi, Regeneron’s Arthritis Drug
EMA Flags Faulty Generic Drug Data, Backs Sales Halt
Spanish Drugmaker Fears Disruption if EMA Moves from Britain
Europe Launches New Fast Approval Scheme for Promising Drugs
